Medtronic reports positive trial data for faecal incontinence therapy
Posted Apr 01 2010 6:14am
Medtronic has published data from a clinical study which demonstrates the efficacy of its new treatment for faecal incontinence .
The company’s InterStim Therapy was tested among 120 sufferers of the condition who had previously failed to respond to other treatment options, with the Medtronic implant helping to achieve a reduction in incontinence episodes .
This device functions by applying mild electrical stimulation to the sacral nerves controlling the bladder, sphincter and pelvic floor muscles, with the aim of delivering perfect continence.
Medtronic senior vice-president and neuromodulation president Tom Tefft stated that the studies show the product’s efficacy in meeting a pressing clinical need.
He said: “InterStim Therapy has a significant impact on quality of life when few other treatment options exist.”
Earlier this month, the company was granted a recommendation from the Food and Drug Administration’s circulatory system devices panel for a new pacemaker optimised for safe use with MRI scanners.